Strengthening India’s indigenous medical device manufacturing capabilities under the Government of India’s Make in India initiative, the Technology Development Board (TDB), Department of Science & ...

Artificial intelligence is moving beyond pilot projects in healthcare. In India, diagnostic centres are increasingly using AI for radiology, pathology, imaging and workflow management. The next ...

India’s medical devices sector is entering a critical phase. The market was valued at approximately USD 14-16 billion in 2025 and is projected to reach around USD 30 billion by 2030. Yet 70 percent–80 ...

Healthcare has entered a new era of technology. Artificial intelligence (AI), regenerative medicine, and digital health have opened up new opportunities for diagnosis, treatment, and rehabilitation.

The field of coagulation diagnostics in India is undergoing a structural shift, moving from foundational screening to advanced, targeted homeostasis management. The focus is not just on purchasing ...

At the start of 2024, India’s MedTech and in-vitro diagnostics (IVD) sector set ambitious goals, aiming for innovation-driven growth, deeper market penetration, and greater accessibility across urban ...

Molecular diagnostics and next-generation sequencing (NGS) are reshaping how oncologists diagnose, classify, and treat cancer. By pivoting from generalized therapies to targeted, genome-driven ...

India’s diagnostic landscape is expanding rapidly, yet the growth remains uneven. The divide between urban and rural India continues to define healthcare outcomes for millions. While metros and Tier-I ...

The MDx shift into integrated, reagent-driven infrastructure is reshaping technology choices, procurement economics, and industry dealmaking. There is a quiet but unmistakable shift underway in how ...

Details regarding the current status of the PLI schemes for pharmaceuticals and their impact on domestic manufacturing are as under: ...

India stands at an important inflection point in healthcare. Over the past two decades, the country has built substantial capabilities in tertiary and quaternary care, supported by advanced medical ...

Anderson Diagnostics and Labs, backed by Tata Capital Healthcare Fund, has initiated a process to raise about ₹250 crore through a mix of primary and secondary transactions, according to two people ...